Inhibikase Therapeutics (IKT) Selling, General & Administrative (2020 - 2026)
Inhibikase Therapeutics (IKT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
-7.36 Mn |
| 10 |
Inhibikase Therapeutics |
285.17 Mn |
114.80 Mn |
- |
7.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
7.38 Mn |
| Dec 31, 2025 |
6.77 Mn |
| Sep 30, 2025 |
5.61 Mn |
| Jun 30, 2025 |
5.92 Mn |
| Mar 31, 2025 |
5.25 Mn |
| Dec 31, 2024 |
5.74 Mn |
| Sep 30, 2024 |
1.64 Mn |
| Jun 30, 2024 |
1.97 Mn |
| Mar 31, 2024 |
2.03 Mn |
| Dec 31, 2023 |
1.40 Mn |
| Sep 30, 2023 |
1.62 Mn |
| Jun 30, 2023 |
1.78 Mn |
| Mar 31, 2023 |
1.93 Mn |
| Dec 31, 2022 |
1.34 Mn |
| Sep 30, 2022 |
1.54 Mn |
| Jun 30, 2022 |
1.66 Mn |
| Mar 31, 2022 |
1.67 Mn |
| Dec 31, 2021 |
1.65 Mn |
| Sep 30, 2021 |
1.64 Mn |
| Jun 30, 2021 |
1.61 Mn |
